Bone Therapeutics SA (0R55.L) Stock Price

€0.002 0%

Sign up
to add to portfolio

AI Score

Sell

  • Alternative

    3

  • Fundamental

    2

  • Technical

    4

Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.

Sign up to get access to more historical data and insights on Bone Therapeutics SA, AI stock picks, stock alerts and much more.

Sign up

0R55.L AI Stock Analysis

AI stock analysis for 0R55.L is missing at the moment.

Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like Bone Therapeutics SA (0R55.L) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.

Sign up and become a member to get access to AI stock analysis.

Sign up

Bone Therapeutics SA (0R55.L) Price Prediction

Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Bone Therapeutics SA (0R55.L), currently trading at €0.002, will... Sign up to access price prediction.

Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.

About 0R55.L

LSE

  • Bone Therapeutics SA, a biotechnology company, engages in the development of cell therapy products for orthopedics and bone diseases.

  • Symbol

    0R55.L

  • Market

    LSE

  • Industry

    Medical - Pharmaceuticals

  • Market Cap

    1.3M

Similar Stocks

0QZU.L Vertex Pharmaceuticals Incorporated
0QZU.L		 $448.8
0.1%
7
0K6R.L Neurocrine Biosciences
0K6R.L		 $125.1
0.3%
7
0IGA.L Emergent BioSolutions Inc.
0IGA.L		 $6.64
1.7%
3
0H7R.L Abeona Therapeutics Inc.
0H7R.L		 $6.57
3.4%
5
0LSZ.L Walgreens Boots Alliance
0LSZ.L		 $11.28
0.3%
4

News

Unicycive Therapeutics Announces Late-Breaker Poster Presentation on Oxylanthanum Carbonate (OLC) at the American Society of Nephrology (ASN) Kidney Week 2024

Unicycive Therapeutics Announces Late-Breaker Poster Presentation on Oxylanthanum Carbonate (OLC) at the American Society of Nephrology (ASN) Kidney Week 2024
October 14, 2024. GlobeNewswire
Facial Injectables Market Poised to Reach US$ 37.1 Billion by 2031, Driven by Growing Demand for Non-Invasive Procedures and Technological Innovations | TMR

Facial Injectables Market Poised to Reach US$ 37.1 Billion by 2031, Driven by Growing Demand for Non-Invasive Procedures and Technological Innovations | TMR
August 2, 2024. PR Newswire UK
Medsenic, subsidiary of BioSenic SA, extends key patent to the United States

Medsenic, subsidiary of BioSenic SA, extends key patent to the United States
July 4, 2024. GlobeNewswire

0R55.L Alternative Data

Web Traffic

Bone Therapeutics SA receives an estimated 0 monthly visitors to bonetherapeutics.com.

  • Web Traffic

    0

  • Change from Previous Month

    0%

  • 3 Month Change

    0%

  • YoY Change

    0%

Twitter Followers

Bone Therapeutics SA has 1,301 Twitter Followers on its main Twitter (also known as X) account, which is down by -0.5% over the last month.

  • Twitter Followers

    1301

  • Daily Change

    0%

  • 1 Month Change

    0.5%

  • 3 Month Change

    0.7%

Facebook Engagement

Bone Therapeutics SA has engaged 1 users via their Facebook Page over the last 7 days.

  • Facebook Engagement

    1

  • Daily Change

    0%

  • 1 Month Change

    0%

  • 3 Month Change

    50%

Youtube Subscribers

Bone Therapeutics SA has 4 subscribers on its main Youtube channel.

  • Youtube Subscribers

    4

  • Daily Change

    0%

  • 1 Month Change

    0%

  • 3 Month Change

    0%

Instagram Followers

Bone Therapeutics SA has 45 Instagram Followers on its main Instagram account.

  • Instagram Followers

    45

  • Daily Change

    0%

  • 1 Month Change

    0%

  • 3 Month Change

    0%

LinkedIn Followers

10,333 are following Bone Therapeutics SA on LinkedIn, down by -0% over the last month.

  • LinkedIn Followers

    10333

  • Daily Change

    0%

  • 1 Month Change

    0%

  • 3 Month Change

    0.3%

Business Outlook

According to employee reviews, the business outlook among employees at Bone Therapeutics SA is 13 out of 100 (very bearish).

  • Business Outlook

    13

  • Change from Previous Month

    0%

  • 3 Month Change

    0%

  • YoY Change

    0%

LinkedIn Employees

According to LinkedIn, Bone Therapeutics SA has 19 employees, down by -5% over the last month.

  • LinkedIn Employees

    19

  • Daily Change

    5%

  • 1 Month Change

    5%

  • 3 Month Change

    5%

News Mentions

Bone Therapeutics SA was mentioned 1 times in the news yesterday.

  • News Mentions

    1

  • Daily Change

    0%

  • 1 Month Change

    0%

  • 3 Month Change

    0%

  • YoY Change

    0%

Reddit Mentions

Bone Therapeutics SA has been mentioned an estimated 0 times in investment subreddits on Reddit over the last 24 hours.

  • Reddit Mentions

    0

  • 1 Month Change

    0%

  • 3 Month Change

    0%

0R55.L Financials

0R55.L Key Metrics

  • Total Revenue

    €1.3M

  • Net Income

    €247.5K

  • Earnings per Share

    €0.0013

  • Free cash flow

    -€417K

  • EBITDA

    -€180.5K

  • EBITDA Ratio

    -0.134001

  • Total Assets

    €9.4M

0R55.L 2-year Revenue & Income
0R55.L 2-year Free Cash Flow

0R55.L Technicals

0R55.L SMA
0R55.L RSI

FAQ

What's the current price of Bone Therapeutics SA (0R55.L) Stock?
The price of an Bone Therapeutics SA (0R55.L) share is €0.002.

What's the market cap of Bone Therapeutics SA?
The current market cap of Bone Therapeutics SA is 1.3M.

Should I buy or sell 0R55.L?
Bone Therapeutics SA exhibits several negative alternative data signals, leading us to expect continued underperformance in the coming months. As a result, we maintain a negative outlook on this stock.

Is Bone Therapeutics SA a good investment?
Considering the fundamentals, technical analysis, and alternative data insights, it may not be the best time to invest in Bone Therapeutics SA stock. There are several bearish signals and market challenges that could negatively impact Bone Therapeutics SA's future performance, suggesting that caution should be exercised before making any investment decisions.

Is now a good time to buy Bone Therapeutics SA (0R55.L) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, it may not be the best time to buy Bone Therapeutics SA stock right now, as the outlook appears bearish.

What are some stocks similar to Bone Therapeutics SA (0R55.L) that investors often compare it to?
Bone Therapeutics SA (0R55.L) is often compared to similar stocks such as Vertex Pharmaceuticals Incorporated, Neurocrine Biosciences, Emergent BioSolutions Inc., Abeona Therapeutics Inc. and Walgreens Boots Alliance.

What is the forecast for Bone Therapeutics SA's stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Bone Therapeutics SA's stock price to be around €0.002 in 2026. Starting from the current price of €0.002, this represents a 0% change in price, indicating a neutral outlook for the stock.

How to buy Bone Therapeutics SA (0R55.L) Stock?
Bone Therapeutics SA stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Bone Therapeutics SA shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.